These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 22301450)

  • 21. Histamine H3 and dopamine D2 receptor-mediated [35S]GTPgamma[S] binding in rat striatum: evidence for additive effects but lack of interactions.
    Humbert-Claude M; Morisset S; Gbahou F; Arrang JM
    Biochem Pharmacol; 2007 Apr; 73(8):1172-81. PubMed ID: 17306767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of anxiety-like responsiveness to the cannabinoid CB(1) receptor agonist HU-210 following chronic stress.
    Hill MN; Gorzalka BB
    Eur J Pharmacol; 2004 Sep; 499(3):291-5. PubMed ID: 15381051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y; Toyoshima R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems.
    Zarrindast MR; Mahboobi S; Sadat-Shirazi MS; Ahmadi S
    J Psychopharmacol; 2011 Jan; 25(1):131-40. PubMed ID: 20685770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: evidence from postmortem human brain.
    Erdozain AM; Diez-Alarcia R; Meana JJ; Callado LF
    Biochem Pharmacol; 2012 Jan; 83(2):260-8. PubMed ID: 22093909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precipitated withdrawal counters the adverse effects of subchronic cannabinoid administration on male rat sexual behavior.
    Riebe CJ; Lee TT; Hill MN; Gorzalka BB
    Neurosci Lett; 2010 Mar; 472(3):171-4. PubMed ID: 20138966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors.
    Centonze D; Rossi S; De Chiara V; Prosperetti C; Battista N; Bernardi G; Mercuri NB; Usiello A; Maccarrone M
    Eur J Neurosci; 2007 Mar; 25(6):1631-40. PubMed ID: 17408430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased brain metabolism after acute administration of the synthetic cannabinoid HU210: a small animal PET imaging study with 18F-FDG.
    Nguyen VH; Verdurand M; Dedeurwaerdere S; Wang H; Zahra D; Gregoire MC; Zavitsanou K
    Brain Res Bull; 2012 Feb; 87(2-3):172-9. PubMed ID: 22155282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellum.
    Selley DE; Cassidy MP; Martin BR; Sim-Selley LJ
    Mol Pharmacol; 2004 Nov; 66(5):1275-84. PubMed ID: 15286206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Residual effects of focal brain ischaemia upon cannabinoid CB(1) receptor density and functionality in female rats.
    Rojo ML; Söderström I; Fowler CJ
    Brain Res; 2011 Feb; 1373():195-201. PubMed ID: 21145311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift?
    Caberlotto L; Rimondini R; Hansson A; Eriksson S; Heilig M
    Neuropsychopharmacology; 2004 Jan; 29(1):15-22. PubMed ID: 12968131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
    Millan MJ; Cussac D; Gobert A; Lejeune F; Rivet JM; Mannoury La Cour C; Newman-Tancredi A; Peglion JL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):903-20. PubMed ID: 14978194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors.
    Leggett JD; Aspley S; Beckett SR; D'Antona AM; Kendall DA; Kendall DA
    Br J Pharmacol; 2004 Jan; 141(2):253-62. PubMed ID: 14707029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoid CB(1) and adenosine A(1) receptors independently inhibit hippocampal synaptic transmission.
    Serpa A; Ribeiro JA; Sebastião AM
    Eur J Pharmacol; 2009 Nov; 623(1-3):41-6. PubMed ID: 19782066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine.
    Rodríguez-Gaztelumendi A; Rojo ML; Pazos A; Díaz A
    J Neurochem; 2009 Mar; 108(6):1423-33. PubMed ID: 19183263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor 'silent antagonist'.
    Gardner A; Mallet PE
    Eur J Pharmacol; 2006 Jan; 530(1-2):103-6. PubMed ID: 16380113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex, drugs, and adult neurogenesis: sex-dependent effects of escalating adolescent cannabinoid exposure on adult hippocampal neurogenesis, stress reactivity, and amphetamine sensitization.
    Lee TT; Wainwright SR; Hill MN; Galea LA; Gorzalka BB
    Hippocampus; 2014 Mar; 24(3):280-92. PubMed ID: 24132958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects.
    Jiang W; Zhang Y; Xiao L; Van Cleemput J; Ji SP; Bai G; Zhang X
    J Clin Invest; 2005 Nov; 115(11):3104-16. PubMed ID: 16224541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligand-induced regulation and localization of cannabinoid CB1 and dopamine D2L receptor heterodimers.
    Przybyla JA; Watts VJ
    J Pharmacol Exp Ther; 2010 Mar; 332(3):710-9. PubMed ID: 20016021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [MIMICKING ISCHEMIC PRECONDITIONING PHENOMENON THROUGH THE IMPACT ON THE CANNABINOID RECEPTORS: ROLE OF PROTEIN KINASE AND NO-SYNTHASE].
    Lishmanov YB; Maslov LN; Krylatov AV; Khaliulin IG
    Ross Fiziol Zh Im I M Sechenova; 2015 Aug; 101(8):909-20. PubMed ID: 26591586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.